Lemuteporfin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLemuteporfin
Drug Alias Namelemuteporfinum来莫泊芬lemuteporfinaQLT-0074DRM-05 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizersApoptosis inducers
TargetsNot applicable
Therapy Area/IndicationsAcne VulgarisProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDermira Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQlt IncDermira Inc
Active IndicationsN/A
Inactive IndicationsAcne VulgarisProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksDrugBank